Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Cell Biol Int ; 46(1): 73-82, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34506671

RESUMO

Oxidative stress role on metformin process of dacarbazine (DTIC) inducing resistance of B16F10 melanoma murine cells are investigated. To induce resistance to DTIC, murine melanoma cells were exposed to increasing concentrations of dacarabazine (DTIC-res group). Metformin was administered before and during the induction of resistance to DTIC (MET-DTIC). The oxidative stress parameters of the DTIC-res group showed increased levels of malondialdehyde (MDA), thiol, and reduced nuclear p53, 8-hydroxy-2'-deoxyguanosine (8-OH-DG), nuclear factor kappa B (NF-ĸB), and Nrf2. In presence of metformin in the resistant induction process to DTIC, (MET-DTIC) cells had increased antioxidant thiols, MDA, nuclear p53, 8-OH-DG, Nrf2, and reducing NF-ĸB, weakening the DTIC-resistant phenotype. The exclusive administration of metformin (MET group) also induced the cellular resistance to DTIC. The MET group presented high levels of total thiols, MDA, and reduced percentage of nuclear p53. It also presented reduced nuclear 8-OH-DG, NF-ĸB, and Nrf2 when compared with the control. Oxidative stress and the studied biomarkers seem to be part of the alterations evidenced in DTIC-resistant B16F10 cells. In addition, metformin administration is able to play a dual role according to the experimental protocol, preventing or inducing a DTIC-resistant phenotype. These findings should help future research with the aim of investigating DTIC resistance in melanoma.


Assuntos
Antineoplásicos Alquilantes/farmacologia , Antioxidantes/farmacologia , Dacarbazina/farmacologia , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Melanoma Experimental/tratamento farmacológico , Metformina/farmacologia , Neoplasias Cutâneas/tratamento farmacológico , 8-Hidroxi-2'-Desoxiguanosina/metabolismo , Animais , Linhagem Celular Tumoral , Malondialdeído/metabolismo , Melanoma Experimental/metabolismo , Melanoma Experimental/patologia , Camundongos , Fator 2 Relacionado a NF-E2/metabolismo , NF-kappa B/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Neoplasias Cutâneas/metabolismo , Neoplasias Cutâneas/patologia , Proteína Supressora de Tumor p53/metabolismo
2.
Pathol Res Pract ; 216(11): 153218, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33002848

RESUMO

Malignant melanoma is the most dangerous form of skin cancer. Despite new therapies for melanoma treatment, effective therapy is mainly limited by excessive metastasis. Currently, the factors determining metastasis development are not elucidated, but oxidative stress was suggested to be involved. To this end, we analyzed oxidative stress parameters during the metastatic development using the syngeneic B16F10 melanoma model. An increase in blood plasma lipid peroxidation occurred at the earliest stage of the disease, with a progressive decrease in oxidative damage and an increase in antioxidant defense. Vice versa, increased lipid peroxidation and 3-nitrotyrosine, and decreased antioxidant parameters were observed in the metastatic nodules throughout the disease. This was concomitant with a progressive increase in vascular endothelial growth factor and proliferating cell nuclear antigen. We conclude that the oxidative stress in the bloodstream decreases during the metastatic process and that nitrosative stress increases during the proliferation and growth of metastatic nodules in the tumor microenvironment. These results will help to better understand the role of oxidative stress during melanoma metastasis.


Assuntos
Neoplasias Pulmonares/secundário , Melanoma/secundário , Metástase Neoplásica/patologia , Estresse Oxidativo/fisiologia , Neoplasias Cutâneas/patologia , Animais , Linhagem Celular Tumoral , Progressão da Doença , Neoplasias Pulmonares/metabolismo , Melanoma/metabolismo , Camundongos , Espécies Reativas de Nitrogênio/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Neoplasias Cutâneas/metabolismo
3.
Pathol Res Pract ; 216(10): 153135, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32853957

RESUMO

High doses of metformin induces oxidative stress (OS) and transforming growth factor ß1 (TGF-ß1) in breast cancer cells, which was associated with increased cancer stem cell population, local invasion, liver metastasis and treatment resistance. Considering the impact of TGF- ß1 and OS in breast cancer and the interrelation between these two pathways, the objective of this work was to investigate the effects of consecutive metformin treatments, at a non-cytotoxic dosage, in TGF- ß1 targets in MCF-7 and MDA-MB-231 cells. Cells were exposed to 6 µM of metformin for seven consecutive passages. Samples were collected to immunocytochemistry (evaluation of p53, Nf-кB, NRF2 and TGF-ß1), biochemical (determination of lipoperoxidation, total thiols and nitric oxide/peroxynitrite levels) and molecular biology analyzes (microarray and Real-time quantitative array PCR). Microarray analysis confirmed alterations in genes related to OS and TGF-ß1. Treatment interfered in several TGF-ß1 target-genes. Metformin upregulated genes involved in OS generation and apoptosis, and downregulated genes associated with metastasis and epithelial mesenchymal transition in MCF-7 cells. In MDA-MB-231 cells, metformin downregulated genes involved with cell invasion, viability and proliferation. The results shows that even a non-cytotoxic dosage of metformin can promote a less aggressive profile of gene expression in breast cancer cells.


Assuntos
Neoplasias da Mama/tratamento farmacológico , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Metformina/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Fator de Crescimento Transformador beta1/metabolismo , Neoplasias da Mama/patologia , Linhagem Celular Tumoral , Regulação para Baixo/efeitos dos fármacos , Feminino , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Invasividade Neoplásica/genética , Fator de Crescimento Transformador beta1/efeitos dos fármacos
4.
Melanoma Res ; 27(6): 536-544, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-28877050

RESUMO

Cutaneous melanoma is one of the most lethal cancers because of its increased rate of metastasis and resistance to available therapeutic options. Early studies indicate that metformin has beneficial effects on some types of cancer, including melanoma. To clarify knowledge of the mechanism of action of metformin on this disease, two treatment-based approaches are presented using metformin on melanoma progression: an in-vitro and an in-vivo model. The in-vitro assay was performed for two experimental treatment periods (24 and 48 h) at different metformin concentrations. The results showed that metformin decreased cell viability, reduced proliferation, and apoptosis was a major event 48 h after treating B16F10 cells. Oxidative stress was characterized by the decrease in total thiol antioxidants immediately following 24 h of metformin treatment and showed an increase in lipid peroxidation. The in-vivo model was performed by injecting B16F10 cells into the subcutaneous of C57/BL6 mice. Treatment with metformin began on day 3 and on day 14, the mice were killed. Treatment of mice with metformin reduced tumor growth by 54% of its original volume compared with nontreatment. The decrease in systemic vascular endothelial growth factor, restoration of antioxidants glutathione and catalase, and normal levels of lipid peroxidation indicate an improved outcome for melanoma following metformin treatment, meeting a need for new strategies in the treatment of melanoma.


Assuntos
Hipoglicemiantes/uso terapêutico , Melanoma Experimental/tratamento farmacológico , Metformina/uso terapêutico , Animais , Proliferação de Células/efeitos dos fármacos , Humanos , Hipoglicemiantes/administração & dosagem , Hipoglicemiantes/farmacologia , Melanoma Experimental/patologia , Metformina/farmacologia , Camundongos , Camundongos Endogâmicos C57BL
5.
J Med Food ; 13(3): 503-8, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20438324

RESUMO

Coccoloba mollis (Family Polygonaceae) is a medicinal plant popularly used in cases of memory loss, stress, insomnia, anemia, impaired vision, and sexual impotence, but the scientific literature, to date, lacks studies on the biological effects of this species, particularly with regard to cytotoxicity and induction of DNA damage. The aim of the present study was to assess in vitro (in hepatic HTC cells) ethanolic extracts of the roots and leaves of C. mollis for cytotoxicity, genotoxicity, and induction of apoptosis. For these evaluations the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay, comet assay, micronucleus test with cytokinesis block, and an in situ test for detection of apoptotic cells with acridine orange staining were used. The results showed that the extract obtained from the roots of C. mollis is more cytotoxic than that obtained from the leaves and that the reduction in cell viability observed in the MTT assay was a result, at least in part, from the induction of apoptosis. Both extracts induced DNA damage at a concentration of 20 microg/mL in the comet assay, but no genotoxicity was detected with any of the treatments carried out in the micronucleus test.


Assuntos
Dano ao DNA/efeitos dos fármacos , Mutagênicos/toxicidade , Extratos Vegetais/toxicidade , Plantas Medicinais/química , Polygonaceae/química , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Ensaio Cometa , Humanos , Testes de Mutagenicidade , Folhas de Planta/química , Raízes de Plantas/química
6.
Semina ; 16(ed.esp): 69-72, set. 1995. graf
Artigo em Português | LILACS | ID: lil-216783

RESUMO

A gravidez na adolescência cosntitui uma das preocupaçöes mais importantes relacionadas à conduta sexual dos adolescentes frente ao percentual cada vez mais elevado da sua ocorrência, em consequência a uma iniciaçäo cada vez mais precoce, sem o uso adequado de métodos anticincepcionais. Além disso, é considerada um importante problema de Saúde Pública por estar intimamente relacionada às altas taxas de mortalidade infantil, perinatal e materna. O presente trabalho foi desenvolvido na Unidade Básica de Saúde do Conjunto Habitacional Maria Cecília e sua área de abrangência (Zona Norte de Londrina), onde dados fornecidos pela 17ª Regional de Saúde mostram ser esta uma regiäo com alto percentual de adolescentes grávidas. Com o objetivo de traçar o perfil dos adolescentes dessa regiäo, foram feitas entrevistas com 25 adolescentes (sexo feminino) na faixa atária entre 13 e 19 anos. Constatamos que das 25 adolescentes (grávidas e/ou já tiveram filhos), 52 por cento casadas atualmente e 44 por cento solteiras, sendo 64 por cento com 1§ grau incompleto e 20 por cento com 1§ grau concluído. As respostas mostram que 68 por cento näo conversam com os pais sobre sexo, as informaçöes säo obtidas principalmente com os amigos (60 por cento) e a prática sexual é iniciada em 64 por cento entre 15 e 16 anos e 24 por cento entre 13 e 14 anos. Os motivos dessa prática precoce incluem sexo como parte do namoro (60 por cento), atraçäo física (16 por cento), rebeldia e desestrutura familiar (8 por cento). Concluímos que a falta de informaçäo näo é o principal fator responsável pelo elevado índice de gravidez na adolescência. Assim, propomos a implantaçäo de programas profissionais tendo adolescentes como populaçäo alvo, que orientem quanto ao uso de métodos contraceptivos e prevençäo contínua, com atendimento integral, multiprofissional e intersetorial


Assuntos
Educação Sexual , Gravidez na Adolescência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...